What's new? Log in Free sign up

Soligenix (SNGX) News and press releases

Company Profile

News

From Benzinga Pro

Soligenix Submits Type A Meeting Request To FDA For HyBryte Marketing Application For Cutaneous T-Cell Lymphoma; Meeting Expected To Occur Approximately 30 Days From FDA's Receipt Of Meeting Request

News, Health Care, FDA, General

HyBryte (research name SGX301) is a novel, first-in-class, photodynamic therapy utilizing safe, visible light for activation. The active ingredient in HyBryte™ is synthetic hypericin, a potent

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 100 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

During Tuesday, 79 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Monday

During Monday's session, 56 companies made new 52-week lows.

Stocks That Hit 52-Week Lows On Friday

On Friday, 135 companies reached new 52-week lows.

12 Health Care Stocks Moving In Wednesday's Intraday Session

Nasdaq Turns Higher; Soligenix Shares Plunge

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.16% to 34,191.46 while the NASDAQ rose 0.51% to 11,952.38. The S&P 500 also rose, gaining, 0.16% to 4,143.79.

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Crude Oil Down 1%; SkyWater Technology Shares Spike Higher

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday. The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P 500 also fell, dropping, 0.63% to 4,111.05.

Stocks That Hit 52-Week Lows On Tuesday

During Tuesday, 40 stocks hit new 52-week lows.

Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42% to 11,842.10. The S&P 500 also fell, dropping, 0.37% to 4,122.02.

Why Are Soligenix Shares Plummeting Today?

Biotech, News, Penny Stocks, Health Care, FDA, Movers, General

Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

The FDA Has Provided Soligenix With A Refusal To File (RTF) Letter For Its Hybryte (Synthetic Hypericin) New Drug Application For Early Stage Cutaneous T-cell Lymphoma (Ctcl), A Rare Cancer.

News, Health Care, FDA, General

Upon preliminary review, the FDA determined that the NDA, submitted on December 14, 2022, was not sufficiently complete to permit substantive review. Soligenix first learned of the RTF decision via this letter and

Stocks That Hit 52-Week Lows On Friday

News, Options, Intraday Update, Markets, Movers, Trading Ideas

During Friday, 48 stocks hit new 52-week lows.

12 Health Care Stocks Moving In Thursday's After-Market Session

Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-market trading on heavy volume.

Press releases

From Benzinga Pro

Soligenix Submits Type A Meeting Request to U.S. FDA for HyBryte™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma

Meeting expected to occur approximately 30 days from the FDA's receipt of meeting request PRINCETON, N.J., March 9, 2023 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage

Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma

Soligenix intends to seek guidance from the FDA on how to further advance HyBryte™ towards potential approval PRINCETON, N.J., Feb. 14, 2023 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the

Soligenix Announces Reverse Stock Split

Stock Split, Press Releases

Common Stock Will Begin Trading on Split-Adjusted Basis on February 10, 2023 PRINCETON, N.J., Feb. 9, 2023 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company

Soligenix Invited to Present at the Virtual Investor Summit Event

Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market PRINCETON, N.J., Jan. 19, 2023 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage

Soligenix Announces Distribution of Series D Preferred Stock to Holders of its Common Stock

Dividends, Small Cap, Press Releases

PRINCETON, N.J., Dec. 23, 2022 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.